Massmutual Trust CO Fsb Catalyst Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 245 shares of CPRX stock, worth $5,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245
Previous 245
-0.0%
Holding current value
$5,230
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
285Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$399 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$195 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$173 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$129 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$64.1 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.2B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...